Finance

Lists
1737:TPE
Taiyen Biotech Co Ltd
NT$30,00
-0,17%
(-0,050) 1D
1 Okt., 13:30:26 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1737...
Open
NT$30,10
High
NT$30,10
Low
NT$30,00
Mkt. cap
6,00 mjd
Avg. vol.
418,57 k
Volume
102,34 k
Dividend
4,67%
Quarterly dividend
NT$0,35
Ex-dividend date
24 Aug. 2026
P/E ratio
15,46
52-wk high
NT$33,00
52-wk low
NT$29,30
EPS
NT$1,94
Shares outstanding
200,00 m
No. of employees
487
Open
NT$30,10
High
NT$30,10
Low
NT$30,00
Mkt. cap
6,00 mjd
Avg. vol.
418,57 k
Volume
102,34 k
Dividend
4,67%
Quarterly dividend
NT$0,35
Ex-dividend date
24 Aug. 2026
P/E ratio
15,46
52-wk high
NT$33,00
52-wk low
NT$29,30
EPS
NT$1,94
Shares outstanding
200,00 m
No. of employees
487
News stories
From web sources and news partners
About Taiyen Biotech Co Ltd
CEO-
Employees487
FoundedMrt. 1952
Headquarters-
Sector-
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
814,82 m
816,45 m
789,50 m
769,01 m
Cost of goods sold
490,84 m
493,63 m
470,53 m
476,19 m
Cost of revenue
490,84 m
495,58 m
470,53 m
476,19 m
Research and development expenses
13,58 m
15,37 m
12,16 m
12,76 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
200,96 m
218,67 m
185,31 m
204,20 m
Operating expense
228,01 m
189,14 m
197,47 m
216,96 m
Total operating expenses
718,85 m
684,72 m
668,00 m
693,14 m
Operating income
95,97 m
131,73 m
121,50 m
75,87 m
Other non operating income
3,63 m
22,69 m
-7,03 m
11,26 m
EBT including unusual items
100,12 m
168,21 m
119,21 m
92,73 m
EBT excluding unusual items
113,55 m
164,10 m
120,68 m
90,82 m
Income tax expense
27,76 m
25,12 m
24,75 m
13,11 m
Effective tax rate
27,73%
14,94%
20,77%
14,14%
Other operating expenses
-
-
-
-
Net income
72,36 m
143,09 m
94,46 m
79,62 m
Net profit margin
8,88%
17,53%
11,96%
10,35%
Earnings per share
-
-
-
-
Interest and investment income
4,43 m
6,07 m
4,22 m
6,08 m
Interest expense
-825,00 k
-784,00 k
-772,00 k
-2,14 m
Net interest expenses
3,61 m
5,29 m
3,45 m
3,93 m
Depreciation and amortization charges
-
-
-
-
EBITDA
160,99 m
194,59 m
185,10 m
139,29 m
Gain or loss from assets sale
48,00 k
2,41 m
-
12,00 k
AI content may include mistakes. Learn more
Google-programme